ELISA in Relapsed/Refractory MM

Clinical trial NCT06832865 · RECRUITING

Trial details

NCT number: NCT06832865
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Refractory Multiple Myeloma (RRMM)Relapsed Refractory Multiple Myeloma

Start date: 2025-08-14
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.